SIRT3 and glioblastoma: Targeting of SIRT3 in GBM cells also led to an obvious decrease in cystine uptake (Fig. 8D), and forced expression of SLC7A11 recovered cystine uptake in U251 cells with SIRT3 knockdown (Fig. 8E, F).